|
Originally published In Press as doi:10.1074/jbc.M008481200 on June 4, 2001
J. Biol. Chem., Vol. 276, Issue 32, 30527-30536, August 10, 2001
Functional Coupling between Secretory and Cytosolic Phospholipase
A2 Modulates Tumor Necrosis Factor- - and
Interleukin-1 -induced NF- B Activation*
Marit W.
Anthonsen ,
Anita
Solhaug, and
Berit
Johansen
From the UNIGEN Center for Molecular Biology, Faculty of Chemistry
and Biology, Norwegian University of Science and Technology,
N-7489 Trondheim, Norway
Tumor necrosis factor (TNF)- and interleukin
(IL)-1 are potent activators of the transcription factor NF- B,
induced during inflammatory conditions. We have previously shown that
both secretory and cytosolic phospholipase A2
(PLA2) are involved in TNF- - and IL-1 -induced NF- B
activation. In this study, we have addressed the mechanism of
PLA2 involvement with respect to downstream arachidonic acid (AA) metabolites and the functional coupling between
PLA2s mediating NF- B activation. We show that in
addition to inhibitors of secretory and cytosolic PLA2s,
5-lipoxygenase inhibitors attenuate TNF- - and IL-1 -stimulated
NF- B activation. Exogenous addition of leukotriene B4
(LTB4) restored NF- B activation reduced by 5-lipoxygenase inhibitors or an LTB4 receptor antagonist,
thus identifying LTB4 as a mediator in signaling to
NF- B. TNF- - and IL-1 -induced AA release from cellular
membranes was accompanied by phosphorylation of cytosolic
PLA2. Inhibitors of secretory PLA2 and of
5-lipoxygenase/LTB4 functionality markedly reduced AA
release and nearly completely abolished cytosolic PLA2
phosphorylation. This demonstrates that secretory PLA2,
through 5-lipoxygenase metabolites, is an essential upstream regulator
of cytosolic PLA2 and AA release. Our results therefore
suggest the existence of a functional link between secretory and
cytosolic PLA2 in cytokine-activated keratinocytes,
providing a molecular explanation for the participation of both
secretory and cytosolic PLA2 in arachidonic acid signaling and NF- B activation in response to proinflammatory cytokines.
*
This work was supported by a grant from the University of
Trondheim (to M. W. A.), Norwegian Research Council Grant 123641/310, and Norwegian Cancer Society Grant A00038/003.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 47-73-551278;
Fax: 47-73-596100; E-mail: Marit.W.Anthonsen@chembio.ntnu.no.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. T. Wijewickrama, J.-H. Kim, Y. J. Kim, A. Abraham, Y. Oh, B. Ananthanarayanan, M. Kwatia, S. J. Ackerman, and W. Cho
Systematic Evaluation of Transcellular Activities of Secretory Phospholipases A2: HIGH ACTIVITY OF GROUP V PHOSPHOLIPASES A2 TO INDUCE EICOSANOID BIOSYNTHESIS IN NEIGHBORING INFLAMMATORY CELLS
J. Biol. Chem.,
April 21, 2006;
281(16):
10935 - 10944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Offer, S. Yedgar, O. Schwob, M. Krimsky, H. Bibi, A. Eliraz, Z. Madar, and D. Shoseyov
Negative feedback between secretory and cytosolic phospholipase A2 and their opposing roles in ovalbumin-induced bronchoconstriction in rats
Am J Physiol Lung Cell Mol Physiol,
March 1, 2005;
288(3):
L523 - L529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oestvang, D. Bonnefont-Rousselot, E. Ninio, J. K. Hakala, B. Johansen, and M. W. Anthonsen
Modification of LDL with human secretory phospholipase A2 or sphingomyelinase promotes its arachidonic acid-releasing propensity
J. Lipid Res.,
May 1, 2004;
45(5):
831 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Munoz, Y. J. Kim, A. Y. Meliton, K. P. Kim, S.-K. Han, E. Boetticher, E. O'Leary, S. Myou, X. Zhu, J. V. Bonventre, et al.
Human Group V Phospholipase A2 Induces Group IVA Phospholipase A2-independent Cysteinyl Leukotriene Synthesis in Human Eosinophils
J. Biol. Chem.,
October 3, 2003;
278(40):
38813 - 38820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. J. Kim, K. P. Kim, S. K. Han, N. M. Munoz, X. Zhu, H. Sano, A. R. Leff, and W. Cho
Group V Phospholipase A2 Induces Leukotriene Biosynthesis in Human Neutrophils through the Activation of Group IVA Phospholipase A2
J. Biol. Chem.,
September 20, 2002;
277(39):
36479 - 36488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Kao, S. Tulac, S. Lobo, B. Imani, J. P. Yang, A. Germeyer, K. Osteen, R. N. Taylor, B. A. Lessey, and L. C. Giudice
Global Gene Profiling in Human Endometrium during the Window of Implantation
Endocrinology,
June 1, 2002;
143(6):
2119 - 2138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. J. Kim, K. P. Kim, H. J. Rhee, S. Das, J. D. Rafter, Y. S. Oh, and W. Cho
Internalized Group V Secretory Phospholipase A2 Acts on the Perinuclear Membranes
J. Biol. Chem.,
March 8, 2002;
277(11):
9358 - 9365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Anthonsen, S. Andersen, A. Solhaug, and B. Johansen
Atypical lambda /iota PKC Conveys 5-Lipoxygenase/Leukotriene B4-mediated Cross-talk between Phospholipase A2s Regulating NF-kappa B Activation in Response to Tumor Necrosis Factor-alpha and Interleukin-1beta
J. Biol. Chem.,
September 14, 2001;
276(38):
35344 - 35351.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|